STENTiT Establishes a Medical Advisory Board

MedTech Outlook | Tuesday, September 21, 2021

Prof. Serruys, Prof. van Sambeek, and Prof. Onuma join STENTiT’s Medical Advisory Board.

FREMONT, CA: STENTiT, a medical device company developing a novel class of regenerative endovascular implants to treat cardiovascular diseases, appoints Medical Advisory Board, which will be chaired by Prof. Patrick Serruys and will include Prof. Marc van Sambeek and Prof. Yoshinobu Onuma.

Bart Sanders, CEO of STENTiT, says, “We are excited to receive the support of these highly esteemed professionals in the current stage of our company development.”

“What is fascinating about STENTiTs technology, is the presence of endoluminal elastin in early preclinical work. Restoring this protective layer in patients would be a unique approach to prevent late-stage neo-atherosclerosis,” says Prof. Serruys, Chairman of the Board, Global Key Opinion Leader, and established professor of interventional medicine and innovation from the CORRIB Core Lab of the National University of Ireland Galway.

Prof. Serruys is a world-renowned expert in interventional cardiology and imaging with over four decades of clinical trial and medical innovation expertise. He invented several interventional methods and devices, including BMS, DES, BRS, and TAVI, and imaging techniques like quantitative coronary angiography, quantitative IVUS, OCT, and near spectroscopy coupled with IVUS. Prof. Serruys has also performed over 90 clinical studies involving over 191,000 patients, is co-author of over 4000 peer-reviewed articles and is the author, co-author, or editor of over 42 volumes, including the European Society of Cardiology's textbook.

“Providing a new regenerative inner surface of the vessel, may be key to improve patency outcomes in peripheral interventions, where so far current alternatives are suboptimal,” adds Prof. van Sambeek, a vascular surgeon at the Catherina Hospital in Eindhoven, the Netherlands, and part-time professor of Application of Engineering in Vascular Surgery and Endovascular Therapy from the department of Biomedical Engineering at the Eindhoven University of Technology.

Prof. van Sambeek is a vascular surgeon at the Catharina Hospital Eindhoven interested in minimally invasive vascular surgery. He also serves as a part-time professor of Engineering Applications in Vascular Surgery and Endovascular Therapy at the Cardiovascular Biomechanics research group of the Eindhoven University of Technology's Department of Biomedical Engineering. He is a practicing scientist who has initiated and participated in several clinical investigations. Prof. van Sambeek is the (co-)author of over 200 peer-reviewed papers in medical journals and over 20 chapters in medical textbooks.

“STENTiT will be one of the unique technologies to overcome the limitations of first generation resorbable devices,” states Prof. Onuma, Professor of interventional cardiology and medical director of Coronary Imaging and Atherosclerosis Research of the CORRIB Core Lab from the National University of Ireland Galway.

Prof. Onuma is an internationally recognized expert in non-invasive and invasive coronary imaging and innovative coronary devices like bioresorbable scaffolds. Quantitative coronary angiography (2-dimensional, 3-dimensional, and bifurcation-specific), Syntax Score, and multi-slice computed tomography are his areas of specialization.

Bart Sanders further concludes, “In the ongoing quest to improve sustained vascular patency, regenerative stents provide a unique approach in combining regenerative medicine with bioresorbable stent technology. By providing temporary scaffolding while simultaneously restoring the artery from the inside-out, we could significantly improve durable clinical outcomes.”